Login to Your Account

Vanda Shares Surge 626% on FDA Approval of Fanapt

By Catherine Hollingsworth

Friday, May 8, 2009
Shares in Vanda Pharmaceuticals Inc. rocketed into the stratosphere Thursday on news of the FDA's surprising approval of the company's antipsychotic Fanapt. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription